Global InsurTech funding climbed 19.5% to $5.1 billion in 2025, breaking a three-year slide, as fourth-quarter investment surged 66.8% to $1.68 billion. AI-focused companies captured 77.9% of that Q4 total, cementing the technology's grip on the sector.
The year's gain - the first since the 2021 peak - was propelled by a jump in mega-rounds over $100 million, from six in 2024 to 11 in 2025, and a 6.4% increase in deal count to 366 transactions. Average deal size rose 14% to $15.79 million, according to the quarterly InsurTech report.
AI captures most of the capital
Roughly three-quarters of all InsurTech funding now flows to businesses carrying the AI label. In Q4 2025, AI-driven firms raised $1.31 billion across 66 deals, with an average ticket of $22.14 million. Across the full year, these companies secured $3.35 billion, or 66% of total funding.
The report's authors note: "We do not see this trend slowing down. In fact, we see AI becoming so integrated into InsurTech over time that the two may well become effectively synonymous." For insurance teams, building practical AI knowledge - through resources like AI for Insurance training - is becoming a baseline requirement.
Investors pivot toward software vendors
The tilt toward B2B technology providers sharpened in 2025. In P&C, 58% of deals went to standalone InsurTech vendors, up 12 percentage points from the 2021 funding boom. Meanwhile, the share claimed by lead generation, broker, and MGA firms fell to a record-low 35%. In L&H, B2B InsurTechs accounted for 64% of deals.
(Re)insurers also stepped up their direct venture activity, completing a record 162 private tech investments during the year. That signals insurers are not only more comfortable writing checks but also see InsurTechs as a route forward in their own strategies.
P&C rebounds; L&H slips
P&C funding recovered from its 2024 trough, rising 34.9% to $3.49 billion, with mega-rounds doing much of the heavy lifting. L&H told a different story: funding fell 4.6% year on year to $1.59 billion, and deal count dropped 17.7% to 102.
U.S. extends its lead
U.S.-based InsurTechs widened their advantage in 2025. Their share of global deals rose 5.16 percentage points to 55.74%, the largest increase among all countries. Activity concentrated even more heavily in Silicon Valley, where deal share jumped from 8.72% to 16.12%. No other market grew by more than one percentage point; India, France, Canada, and Germany all lost ground.
Early-stage funding dips but check sizes grow
Early-stage InsurTech funding slipped 9.1% year on year to $1.11 billion, with deal count edging down from 193 to 185. Even so, the average early-stage round rose 12.1% to $6.6 million, pointing to steady demand for younger firms that did secure backing. The number of active InsurTech investors also increased for the first time since 2021, climbing from 788 to 852.
Why this matters for insurance professionals
The flood of capital into AI-first vendors and B2B technology platforms is reshaping the supplier landscape. Carriers and brokers that delay evaluating AI tools for underwriting, claims, or distribution risk losing ground to competitors already partnering with these funded startups. The record direct investment from (re)insurers shows the technology is moving from experiment to strategic necessity, and the shift away from consumer-facing models suggests the next wave of efficiency gains will come from software that makes existing insurance operations faster and smarter.
Your membership also unlocks:
